adibendan has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietz, R; Haass, M; Kapp, M; Kübler, W; Neumann, FJ; Rauch, B; Smolarz, A; Tillmanns, H; Von Molitor, S; Zimmermann, R | 1 |
| May, E; Peters, P; Saborowski, F; Schneider, M | 1 |
2 other study(ies) available for adibendan and Chronic Disease
| Article | Year |
|---|---|
Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
Topics: Adult; Benzimidazoles; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Neurosecretory Systems; Oxindoles; Phosphodiesterase Inhibitors | 1991 |
[Central hemodynamics of a new positive inotropic substance, adibendan. Data from a dose-finding study].
Topics: Aged; Benzimidazoles; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxindoles; Pulmonary Circulation; Stroke Volume; Vasodilator Agents | 1990 |